ACR 2022 Tweet by Catherine Sims, MD

Tweet
Catherine Sims, MD @DrCassySims Nov 12, 2022
View on
Xeljanz in PsA (@pfizer funded) #ACR22 @RheumNow

⚠️safety data
-Pancytopenia
-Transaminitis
-Dyslipidemia
-Elevated CPK without #myositis
-Avoid in pregnancy and GI strictures

🤰Stop JAKi at least one month prior to conception🤰

Related Content

Article Education/ACR/EULAR

Mixed Drinks, Mixed Results (10.30.2026)

Jack Cush, MD Oct 30, 2026
Dr. Cush reviews the news and journal reports from this past week on RheumNow. This week on the podcast: hopeful guidelines for PMR; certainty about good & bad beverages in gout; mixed results in Sjogren's; non-lupus drugs saves lupus lives; and big hips sink ships in psoriatic arthritis…
Article Education/ACR/EULAR

Double Trouble (10.23.2026)

Jack Cush, MD Oct 23, 2026
Dr. Jack Cush reviews the journal articles and regulatory announcements from this past week on RheumNow, including: two crystals in one joint, twice the cryptococcus risk in JAKs; Myositis and Scleroderma; and Sjögren’s plus early damage = >> 2 fold risk lymphoma. Double trouble week on the RheumNow podcast.
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Topics

×